ATE218866T1 - Kombinationstherapie zur behandlung von aids - Google Patents
Kombinationstherapie zur behandlung von aidsInfo
- Publication number
- ATE218866T1 ATE218866T1 AT98959424T AT98959424T ATE218866T1 AT E218866 T1 ATE218866 T1 AT E218866T1 AT 98959424 T AT98959424 T AT 98959424T AT 98959424 T AT98959424 T AT 98959424T AT E218866 T1 ATE218866 T1 AT E218866T1
- Authority
- AT
- Austria
- Prior art keywords
- aids
- treatment
- combination therapy
- therapy
- combination
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 title 1
- 238000002648 combination therapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6542197P | 1997-11-13 | 1997-11-13 | |
| GBGB9807938.7A GB9807938D0 (en) | 1998-04-15 | 1998-04-15 | Combination therapy for the treatment of AIDS |
| US9094098P | 1998-06-26 | 1998-06-26 | |
| GBGB9819590.2A GB9819590D0 (en) | 1998-09-08 | 1998-09-08 | Combination therapy for the treatment of aids |
| PCT/US1998/024097 WO1999025352A1 (en) | 1997-11-13 | 1998-11-12 | Combination therapy for the treatment of aids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE218866T1 true ATE218866T1 (de) | 2002-06-15 |
Family
ID=27451773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98959424T ATE218866T1 (de) | 1997-11-13 | 1998-11-12 | Kombinationstherapie zur behandlung von aids |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1044000B1 (de) |
| JP (1) | JP2001522889A (de) |
| KR (1) | KR20010032055A (de) |
| CN (1) | CN1285747A (de) |
| AR (1) | AR013758A1 (de) |
| AT (1) | ATE218866T1 (de) |
| AU (1) | AU749795B2 (de) |
| BG (1) | BG104507A (de) |
| BR (1) | BR9814146A (de) |
| CA (1) | CA2309164A1 (de) |
| CO (1) | CO4970782A1 (de) |
| DE (1) | DE69806062T2 (de) |
| EA (1) | EA200000513A1 (de) |
| ES (1) | ES2177103T3 (de) |
| HU (1) | HUP0100365A3 (de) |
| ID (1) | ID24922A (de) |
| IL (1) | IL135994A0 (de) |
| IS (1) | IS5481A (de) |
| NO (1) | NO20002481L (de) |
| PE (1) | PE20000020A1 (de) |
| PL (1) | PL340430A1 (de) |
| SK (1) | SK6842000A3 (de) |
| TR (1) | TR200001938T2 (de) |
| WO (1) | WO1999025352A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| WO2003011221A2 (en) | 2001-07-30 | 2003-02-13 | University Of Southern California | PREPARATION AND USE OF α-KETO PHOSPHONATES |
| JP4996241B2 (ja) | 2003-01-14 | 2012-08-08 | ギリアード サイエンシーズ， インコーポレイテッド | 組み合わせ抗ウイルス治療のための組成物および方法 |
| GB2400553A (en) * | 2003-04-14 | 2004-10-20 | Cipla Ltd | Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof |
| TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
| TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI962488A7 (fi) * | 1993-12-15 | 1996-06-14 | Merck & Co Inc | HIV:n proteaasin inhibiittoreita |
-
1998
- 1998-11-11 CO CO98066470A patent/CO4970782A1/es unknown
- 1998-11-12 EP EP98959424A patent/EP1044000B1/de not_active Expired - Lifetime
- 1998-11-12 WO PCT/US1998/024097 patent/WO1999025352A1/en not_active Ceased
- 1998-11-12 CN CN98813077A patent/CN1285747A/zh active Pending
- 1998-11-12 ES ES98959424T patent/ES2177103T3/es not_active Expired - Lifetime
- 1998-11-12 HU HU0100365A patent/HUP0100365A3/hu unknown
- 1998-11-12 ID IDW20000895A patent/ID24922A/id unknown
- 1998-11-12 SK SK684-2000A patent/SK6842000A3/sk unknown
- 1998-11-12 PL PL98340430A patent/PL340430A1/xx unknown
- 1998-11-12 CA CA002309164A patent/CA2309164A1/en not_active Abandoned
- 1998-11-12 AT AT98959424T patent/ATE218866T1/de not_active IP Right Cessation
- 1998-11-12 DE DE69806062T patent/DE69806062T2/de not_active Expired - Fee Related
- 1998-11-12 EA EA200000513A patent/EA200000513A1/ru unknown
- 1998-11-12 AR ARP980105720A patent/AR013758A1/es unknown
- 1998-11-12 KR KR1020007005176A patent/KR20010032055A/ko not_active Withdrawn
- 1998-11-12 AU AU15225/99A patent/AU749795B2/en not_active Ceased
- 1998-11-12 IL IL13599498A patent/IL135994A0/xx unknown
- 1998-11-12 JP JP2000520785A patent/JP2001522889A/ja not_active Withdrawn
- 1998-11-12 BR BR9814146-5A patent/BR9814146A/pt not_active Application Discontinuation
- 1998-11-12 TR TR2000/01938T patent/TR200001938T2/xx unknown
- 1998-11-12 PE PE1998001094A patent/PE20000020A1/es not_active Application Discontinuation
-
2000
- 2000-05-09 IS IS5481A patent/IS5481A/is unknown
- 2000-05-12 NO NO20002481A patent/NO20002481L/no not_active Application Discontinuation
- 2000-06-05 BG BG104507A patent/BG104507A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA200000513A1 (ru) | 2000-10-30 |
| PL340430A1 (en) | 2001-02-12 |
| HUP0100365A2 (hu) | 2002-05-29 |
| TR200001938T2 (tr) | 2001-07-23 |
| DE69806062T2 (de) | 2003-03-20 |
| HUP0100365A3 (en) | 2002-06-28 |
| IL135994A0 (en) | 2001-05-20 |
| KR20010032055A (ko) | 2001-04-16 |
| CO4970782A1 (es) | 2000-11-07 |
| SK6842000A3 (en) | 2000-12-11 |
| AU749795B2 (en) | 2002-07-04 |
| CA2309164A1 (en) | 1999-05-27 |
| DE69806062D1 (de) | 2002-07-18 |
| CN1285747A (zh) | 2001-02-28 |
| BG104507A (bg) | 2001-03-30 |
| ID24922A (id) | 2000-08-31 |
| WO1999025352A1 (en) | 1999-05-27 |
| NO20002481D0 (no) | 2000-05-12 |
| EP1044000B1 (de) | 2002-06-12 |
| BR9814146A (pt) | 2000-10-03 |
| JP2001522889A (ja) | 2001-11-20 |
| AU1522599A (en) | 1999-06-07 |
| IS5481A (is) | 2000-05-09 |
| PE20000020A1 (es) | 2000-01-27 |
| EP1044000A1 (de) | 2000-10-18 |
| AR013758A1 (es) | 2001-01-10 |
| NO20002481L (no) | 2000-07-12 |
| ES2177103T3 (es) | 2002-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69829921D1 (de) | Vorrichtung zur Behandlung von Körpergewebe | |
| DE69903543D1 (de) | Formulierungen zur behandlung von magen-speiseröhren reflux | |
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE69827424D1 (de) | Vorrichtung zur gesteuerten thermischen Behandlung von Gewebe | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| ATE235481T1 (de) | Substituierte benzopyranderivate zur behandlung von entzündungen | |
| DE69925306D1 (de) | Behandlung von kohlenwasserstoffgas | |
| DE69739303D1 (de) | Vorrichtung zur thermischen behandlung von gewebe | |
| ATE271038T1 (de) | 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen | |
| DE50009504D1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
| DE69936335D1 (de) | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen | |
| DE69924750D1 (de) | Gerät zur thermischen behandlung von gewebe | |
| DE69926385D1 (de) | Behandlung von geweben | |
| EP0709090A3 (de) | Zusammensetzungen zur Behandlung von resistenten Tumoren | |
| ATE292134T1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
| DE69729817D1 (de) | Behandlung von Aldehyd-fixierten Geweben | |
| DE69711311D1 (de) | Vorrichtung zur thermischen Behandlung von Gewebe | |
| ATE267180T1 (de) | Phosphorderivate zur behandlung von aids | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE69807466D1 (de) | Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten | |
| DE69737067D1 (de) | Vakzine zur behandlung von mycosen | |
| ATE226071T1 (de) | Antikonvulsive derivate zur behandlung von neuropathischem schmerz | |
| DE69822297D1 (de) | Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten | |
| DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
| DE60021252D1 (de) | Antikonvulsiva zur behandlung von autismus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |